Gerardo Rivera, PA-C

Gerardo Rivera practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Gerardo Rivera's NPI, 1992399125, was assigned on February 28, 2021. Gerardo Rivera holds Texas license PA14388.

Gerardo Rivera's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Gerardo Rivera's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Gerardo Rivera to 1 more therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gerardo Rivera practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Gerardo Rivera's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Gerardo Rivera is licensed in Texas.

CMS data shows 27 Medicare services from Gerardo Rivera across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $1,333 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Gerardo Rivera in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Gerardo Rivera's median patient age at 70, with 14% women.

In 2024, Gerardo Rivera wrote 703 Medicare Part D claims for 253 patients. 89% of them were for generic drugs. CMS names the drug for 569 of them, across 14 drugs with 11 or more claims each, at $258,937 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Gerardo Rivera for performance year 2024, reported as part of a group. Gerardo Rivera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gerardo Rivera as offering telehealth.

CMS Open Payments shows 60 general payments to Gerardo Rivera from 21 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $277.